Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Bipolar Depression
Interventions
DRUG

Lisdexamfetamine

Start at 20 mg daily. Increased to a maximum of 40 mg daily. Can be decreased in 10 mg increments.

DRUG

Placebo

Subjects will receive placebo matched to lisdexamfetamine.

Trial Locations (1)

02135

Steward St. Elizabeth's Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Steward St. Elizabeth's Medical Center of Boston, Inc.

OTHER